Insulet Corp (PODD.OQ)
PODD.OQ on NASDAQ Stock Exchange Global Select Market
86.69USD
20 Apr 2018
86.69USD
20 Apr 2018
Change (% chg)
$-1.76 (-1.99%)
$-1.76 (-1.99%)
Prev Close
$88.45
$88.45
Open
$88.28
$88.28
Day's High
$89.63
$89.63
Day's Low
$86.36
$86.36
Volume
122,043
122,043
Avg. Vol
147,962
147,962
52-wk High
$89.63
$89.63
52-wk Low
$38.43
$38.43
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.16 | December | 21 Apr 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 7 | 6 | 6 | 6 |
| (2) OUTPERFORM | 4 | 5 | 4 | 4 |
| (3) HOLD | 6 | 6 | 6 | 6 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.94 | 2.00 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 15 | 131.54 | 137.90 | 125.30 | 118.74 |
| Quarter Ending Sep-18 | 15 | 154.47 | 158.00 | 150.80 | 125.23 |
| Year Ending Dec-18 | 18 | 572.93 | 588.00 | 565.80 | 493.07 |
| Year Ending Dec-19 | 17 | 699.61 | 731.00 | 662.57 | 565.92 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 17 | -0.16 | -0.10 | -0.23 | -0.02 |
| Quarter Ending Sep-18 | 17 | 0.00 | 0.09 | -0.27 | 0.02 |
| Year Ending Dec-18 | 17 | -0.33 | -0.20 | -0.90 | -0.08 |
| Year Ending Dec-19 | 17 | 0.31 | 0.71 | 0.04 | 0.10 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-17 | 125.15 | 130.52 | 5.37 | 4.29 |
| Quarter Ending Sep-17 | 114.41 | 121.78 | 7.37 | 6.44 |
| Quarter Ending Jun-17 | 106.17 | 109.76 | 3.59 | 3.38 |
| Quarter Ending Mar-17 | 97.83 | 101.71 | 3.88 | 3.97 |
| Quarter Ending Dec-16 | 100.61 | 103.57 | 2.96 | 2.94 |
| Earnings (per share) | ||||
| Quarter Ending Dec-17 | -0.08 | -0.12 | 0.04 | -53.65 |
| Quarter Ending Sep-17 | -0.10 | -0.04 | 0.06 | -60.24 |
| Quarter Ending Jun-17 | -0.13 | -0.13 | 0.00 | -1.48 |
| Quarter Ending Mar-17 | -0.15 | -0.17 | 0.02 | -10.17 |
| Quarter Ending Dec-16 | -0.05 | -0.16 | 0.11 | -220.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 131.54 | 131.54 | 131.95 | 127.22 | 118.74 |
| Quarter Ending Sep-18 | 154.47 | 154.47 | 154.41 | 149.67 | 125.23 |
| Year Ending Dec-18 | 572.93 | 572.93 | 573.09 | 554.27 | 493.07 |
| Year Ending Dec-19 | 699.61 | 699.27 | 701.33 | 677.66 | 565.92 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | -0.16 | -0.16 | -0.16 | -0.12 | -0.02 |
| Quarter Ending Sep-18 | 0.00 | 0.00 | -0.00 | 0.00 | 0.02 |
| Year Ending Dec-18 | -0.33 | -0.33 | -0.34 | -0.26 | -0.08 |
| Year Ending Dec-19 | 0.31 | 0.31 | 0.31 | 0.23 | 0.10 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-18 | 0 | 0 | 1 | 0 |
| Quarter Ending Sep-18 | 0 | 0 | 1 | 0 |
| Year Ending Dec-18 | 0 | 0 | 1 | 0 |
| Year Ending Dec-19 | 1 | 1 | 2 | 1 |
| Earnings | ||||
| Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Sep-18 | 0 | 0 | 1 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 1 | 1 | 1 | 1 |
Earnings vs. 
Estimates- BRIEF-Insulet Corp Says CEO's 2017 Total Compensation Was $8.2 Mln Vs $6 Mln In 2016
- UPDATE 1-Ypsomed says 2019/20 profit to fall, followed by rebound
- BRIEF-Insulet Corp Posts Q4 Loss Per Share $0.12
- BRIEF-Ascensia Diabetes Care Enters Strategic Alliance With Insulet Corp
- BRIEF-Insulet announces pricing of convertible senior notes due 2024